Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC)
Abstract Stereotactic body radiotherapy (SBRT) applies high doses and requires advanced techniques to spare surrounding tissue in the presence of organ motion. In this work patient individual phase gating is investigated. We studied peripheral and central primary lung tumors. The internal target vol...
Main Authors: | K. M. Kraus, M. Oechsner, J. J. Wilkens, K. A. Kessel, S. Münch, S. E. Combs |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-85031-w |
Similar Items
-
Stereotactic body radiotherapy (SBRT) in patients with lung metastases - prognostic factors and long-term survival using patient self-reported outcome (PRO)
by: Kerstin A. Kessel, et al.
Published: (2020-05-01) -
Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases
by: Theresa Voglhuber, et al.
Published: (2020-06-01) -
Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial
by: Christian D. Diehl, et al.
Published: (2019-11-01) -
Long-Term Survival and Failure Outcomes of Single-Fraction Stereotactic Body Radiation Therapy in Early Stage NSCLC
by: Austin J. Iovoli, MD, et al.
Published: (2023-12-01) -
The impact of histology in the outcomes of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) and adjuvant chemotherapy
by: Vinicius Ernani, et al.
Published: (2020-01-01)